Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Yogurt giant Chobani has confidentially filed a draft registration statement with the US Securities and Exchange Commission, indicating it plans to conduct an initial public offering in the US. We'll update this page as new information becomes available.
Greek yogurt maker Chobani is expected to come to market with an initial public offering, confidentially filing paperwork to do so with the US Securities and Exchange Commission.
The dairy section titan is reportedly seeking a $10 billion valuation in the deal. Neither the timing nor the price details have been released at this time.
We'll update this page as news is released.
Once Chobani goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.
It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. But evaluating the performance of companies like Chobani can be useful in determining how the market is performing and whether now is a good time to invest in this industry. Select a company to learn more about what they do and how their stock performs, including market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield. While this list includes a selection of the most well-known and popular stocks, it doesn't include every stock available.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 10, 2021
Everything we know about the Sunshine Biopharma IPO, plus information on how to buy in.
Everything we know about the Impossible Foods IPO, plus information on how to buy in.
Everything we know about the TDCX IPO, plus information on how to buy in.
Everything we know about the First Watch Restaurant Group IPO, plus information on how to buy in.
Everything we know about the HeartBeam IPO, plus information on how to buy in.
Everything we know about the Augmedix IPO, plus information on how to buy in.
Everything we know about the Allvue Systems Holdings IPO, plus information on how to buy in.
Everything we know about the Cyngn IPO, plus information on how to buy in.
Everything we know about the Cue Health IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.